Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
BACKGROUND: Morbidly obese patients enrolled in a rapid weight reduction program are at a high risk of developing gallstones . Two multicenter, placebo-controlled, randomized, double-blind trials have ...
retrospectively from a cohort of 230 morbidly obese patients who underwent gastric bypass surgery. The index group consisted of 18 patients who were found to have gallstones at gastric bypass surgery and had ...
suggest that UDCA is fully effective in preventing gallstone formation following VBG in patients who follow the prescribed regimen. Obesity Surgery, 3, 25 7-259 A Double-Blind Placebo-controlled Trial ...
JrJKWrightJPDebelakTMAllosYShyrWCChapmanPrevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.J Surg Res.2002;102:50-56.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez ...
system.6,7 Each citation was evaluated for patient population (pediatric versus adult, obese versus nonobese), proper use of the Centers for Disease Control and Prevention’s definitions of obesity ...
morbidly obese patients who underwent open or laparoscopic GBP between January 2003 and December 2006. Main Outcome Measures Complications were stratified by grade: grade I, only bedside procedure; grade II ...
ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss.Am J Surg.1995;169:91-97.Mark A. Vierra, MD, Stanford, Calif:Dr Higa has presented today a remarkable ...
clinical guidelines are valid for 3 yr, after which time they are revised. 1.0 The problem with obesity The objective of interventions in overweight and obese patients is the prevention or amelioration ...
of this cancer in association with obesity seen at meta-analysis (Table 3) is due to the increased formation of gallstones in obese patients alone or in combination with other obesity -related factors requires ...
patients and the need for repeat doses during prolonged procedures.13–18 Obesity has been linked to an increased risk for SSI. The pharma-cokinetics of drugs may be altered in obese patients , so dosage ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!